FDA, Industry Haggle Over Price For New User Fee Deal
By
Jessica Bylander / Email the Author / “The Gray Sheet” Jan. 16, 2012, Vol. 38, No. 03
Regulatory / Word Count: 1230 / Article # 01120116025
Executive Summary
As of last month, FDA and industry were several hundred million dollars apart, according to recently released negotiation meeting minutes. And insiders suggest the two are still haggling over the total amount companies will need to shell out in the five-year user fee reauthorization.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.